Table 1 Baseline clinical characteristics for patients with a history of late or very late stent thrombosis (LST/VLST) and controls.
Characteristics | (V)LST group (n = 20) | PCI Control group (n = 32) | P |
|---|---|---|---|
Demographics | |||
Age (years)* | 53.8 ± 8.6 | 56.9 ± 9.7 | 0.25 |
Female gender, n (%) | 4 (20) | 8 (25) | 0.75 |
BMI kg/m2 * | 26.0 ± 3.6 | 25.9 ± 3.7 | 0.87 |
Alcohol consumption (U/week)* | 3.8 ± 3.7 | 3.1 ± 3.4 | 0.50 |
Current smoking n (%) | 7 (35) | 9 (28) | 0.76 |
Previous smoker n (%) | 11 (55) | 19 (59) | 0.78 |
Angina pectoris (%) | 3 (15) | 7 (22) | 0.72 |
Congestive heart failure n (%) | 2 (10) | 2 (6) | 0.63 |
Hypertension n (%) | 5 (25) | 12 (38) | 0.38 |
Diabetes mellitus n (%) | 3 (15) | 5 (16) | 1.00 |
Hypercholesterolemia n (%) | 9 (45) | 11 (34) | 0.56 |
Coagulation disorders n (%) | 1 (5) | 0 (0) | 0.39 |
Current active infections n (%) | 2 (10) | 4 (13) | 1.00 |
Chronic inflammatory disorders n (%) | 1 (5) | 5 (16) | 0.39 |
Antiphospholipid syndrome n (%) | 0 | 0 | 1.00 |
Pregnancy n (%) | 0 | 0 | 1.00 |
Active malign disease n (%) | 0 | 0 | 1.00 |
Previous MI n (%) | 20 (100) | 31 (97) | 1.00 |
No of previous MI (n)* | 1.8 ± 0.6 | 1.1 ± 0.4 | <0.01 |
Family history of CHD n (%) | 15 (75) | 21 (66) | 0.55 |
Previous VTE n (%) | 0 | 0 | 1.00 |
Family history of VTE n (%) | 5 (25) | 5 (16) | 0.48 |
Previous stroke n (%) | 1 (5) | 0 (0) | 0.39 |
Previous PAD n (%) | 1 (5) | 1 (3) | 1.00 |
Coronary artery bypass graft n (%) | 1 (5) | 2 (6) | 0.85 |
Current medication | |||
Acetylsalicylic acid n (%) | 20 (100) | 32(100) | 1.00 |
Clopidogrel, n (%) | 18 (90) | 29 (91) | 1.00 |
Warfarin n (%) | 0 | 0 | 1.00 |
Angiotensin converting enzyme inhibitor n (%) | 11(55) | 15(47) | 0.78 |
Angiotensin-2 receptor blocker, n (%) | 5 (25) | 10 (31) | 0.76 |
Beta blocker n (%) | 9 (45) | 12 (38) | 0.77 |
Calcium channel blocker n (%) | 0 (0) | 2 (6) | 0.52 |
Aldosteron antagonist n (%) | 5 (25) | 3 (9) | 0.24 |
Insulin n (%) | 1 (5) | 0 (0) | 0.39 |
Oral antidiabetics n (%) | 1 (5) | 4 (13) | 0.64 |
NSAID n (%) | 0 (0) | 1 (3) | 1.00 |
Statin n (%) | 19 (95) | 31 (97) | 1.00 |
Hormone replacement therapy n (%) | 0 (0) | 1 (3) | 1.00 |